Showing 1 - 7 results of 7 for search 'Istvan Petak', query time: 0.03s Refine Results
  1. 1
    HeurAA: accurate and fast detection of genetic variations with a novel heuristic amplicon aligner program for next generation sequencing.

    HeurAA: accurate and fast detection of genetic variations with a novel heuristic amplicon aligner program for next generation sequencing. by Lőrinc S Pongor, Ferenc Pintér, István Peták

    Published 2013-01-01
    Get full text
    Article
  2. 2
    Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells.

    Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells. by Zsuzsanna A Dunai, Gergely Imre, Gabor Barna, Tamas Korcsmaros, Istvan Petak, Pal I Bauer, Rudolf Mihalik

    Published 2012-01-01
    Get full text
    Article
  3. 3
    Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers.

    Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers. by Diána Brauswetter, Bianka Gurbi, Attila Varga, Edit Várkondi, Richárd Schwab, Gábor Bánhegyi, Orsolya Fábián, György Kéri, István Vályi-Nagy, István Peták

    Published 2017-01-01
    Get full text
    Article
  4. 4
    Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, <i>ALK</i>-Positive, <i>TP53</i>-Mutant NSCLC

    Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, <i>ALK</i>-Positive, <i>TP53</i>-Mutant NSCLC by László Urbán, Róbert Dóczi, Barbara Vodicska, Dóra Kormos, László Tóth, István Takács, Edit Várkondi, Dóra Tihanyi, Dóra Lakatos, Anna Dirner, István Vályi-Nagy, István Peták

    Published 2020-08-01
    Get full text
    Article
  5. 5
    The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers–In Vitro Studies

    The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers–In Vitro Studies by Bianka Gurbi, Diána Brauswetter, Attila Varga, Pál Gyulavári, Kinga Pénzes, József Murányi, Veronika Zámbó, Ede Birtalan, Tibor Krenács, David Laurence Becker, Miklós Csala, István Vályi-Nagy, István Peták, Kornél Dános

    Published 2019-11-01
    Get full text
    Article
  6. 6
    Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support

    Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support by Judita Szkukalek, Róbert Dóczi, Anna Dirner, Ákos Boldizsár, Ágnes Varga, Júlia Déri, Dóra Lakatos, Dóra Tihanyi, Barbara Vodicska, Richárd Schwáb, Gábor Pajkos, Edit Várkondi, István Vályi-Nagy, Dorottya Valtinyi, Zsuzsanna Nagy, István Peták

    Published 2021-10-01
    Get full text
    Article
  7. 7
    A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial

    A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial by Istvan Petak, Maud Kamal, Anna Dirner, Ivan Bieche, Robert Doczi, Odette Mariani, Peter Filotas, Anne Salomon, Barbara Vodicska, Vincent Servois, Edit Varkondi, David Gentien, Dora Tihanyi, Patricia Tresca, Dora Lakatos, Nicolas Servant, Julia Deri, Pauline du Rusquec, Csilla Hegedus, Diana Bello Roufai, Richard Schwab, Celia Dupain, Istvan T. Valyi-Nagy, Christophe Le Tourneau

    Published 2021-06-01
    Get full text
    Article

Search Tools: